Novotech Appoints Anand Tharmaratnam as CEO
January 16, 2026
New leader will be based at the company’s new global headquarters in Singapore
1 min read
False
January 16, 2026
New leader will be based at the company’s new global headquarters in Singapore
1 min read
January 12, 2026
New capability frees up human capital from one of the biggest labor costs in clinical research
1 min read
By Stephen Tindal
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
By HH Kim
January 8, 2026
A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.
3 min read
January 7, 2026
The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.
6 min read
By Anita Modi
December 29, 2025
Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.
5 min read
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
By Andrew Riso
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
December 10, 2025
Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing
3 min read
False
False
False